Profile
AYTU ZTS TAK HLN TEVA NBIX
Company Name Aytu BioPharma, Inc. Zoetis Inc. Takeda Pharmaceutical Company Limited Haleon plc Teva Pharmaceutical Industries Limited Neurocrine Biosciences, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $10.33M $77.92B $43.43B $43.25B $20.24B $15.52B
Employees 0.10K 14.10K 49.28K 25.41K 37.00K 1.70K
CEO Mr. Joshua R. Disbrow Ms. Kristin C. Peck Mr. Christophe Weber Mr. Brian James McNamara Mr. Richard D. Francis Mr. Kyle W. Gano Ph.D.
Ratings
AYTU ZTS TAK HLN TEVA NBIX
Quant Rating Score 3 3 3 3 1 4
Quant Rating Neutral Neutral Neutral Neutral Strong Sell Buy
Trading
AYTU ZTS TAK HLN TEVA NBIX
Last Close $1.68 $172.71 $13.7 $9.57 $17.84 $153.29
High 52 $3.36 $199.94 $15.08 $10.69 $22.77 $153.29
Low 52 $1.34 $145.54 $12.6 $8.01 $12.01 $111.62
Price vs. 52 Week High -50 % -13.62 % -9.15 % -10.48 % -21.65 % 0 %
Price vs. 52 Week Low 25.37 % 18.67 % 8.73 % 19.48 % 48.54 % 37.33 %
Total Return
AYTU ZTS TAK HLN TEVA NBIX
1 Month Return -1.18 % 6 % 3.47 % 0.31 % -19.06 % 12.3 %
3 Month Return -12.5 % -3.4 % -1.72 % -1.24 % -3.25 % 27.45 %
6 Month Return -36.6 % -4.07 % -1.3 % 4.59 % 2.35 % 8.28 %
9 Month Return -41.93 % 8.97 % 3.87 % 14.61 % 27.61 % 7.17 %
YTD Return -1.18 % 6 % 3.47 % 0.31 % -19.06 % 12.3 %
1 Year Return -38.46 % -8.04 % -6.16 % 16.71 % 47.44 % 9.67 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AYTU ZTS TAK HLN TEVA NBIX
Dividend Yield Percentage (TTM) - 1.04 % 4.56 % 1.65 % - -
Dividend Paid and Capex Coverage Ration (TTM) -17.4 % 2.1 % 1.34 % - 3.8 % 13.12 %
Dividend Per Share (TTM) - 1.8 % 192 % 0.06 % - -
Payout Ratio (TTM) - 31.44 % 101.62 % - - -
Growth
AYTU ZTS TAK HLN TEVA NBIX
Asset Growth -13.46 % -4.28 % 8.25 % -2.18 % -1.2 % 37.27 %
Gross Profit Growth -18.08 % 3.7 % 1.76 % 5.84 % 9.65 % 26.06 %
Revenue Growth -24.58 % 5.74 % 5.87 % 4.09 % 6.17 % 26.76 %
Revenue 3 Year -81.28 % 31.98 % 33.13 % 13.9 % -6.91 % 71.93 %
Revenue 5 Year -92.21 % 53.64 % 103.83 % 32.87 % -23.33 % 308.36 %
Revenue 10 Year -99.78 % 103.1 % 152.69 % 32.87 % -40.82 % 44100.16 %
EBIT Growth 69.21 % 6.27 % -56.36 % 9.37 % -84.52 % 0.76 %
Net Income Growth 7.07 % 10.88 % -54.56 % -1.04 % 76.24 % 61.62 %
Net Income 3 Yeari Growth Per Share 95.88 % 47.55 % -61.74 % -8.67 % 86.29 % -41.58 %
Net Income 5 Yeari Growth Per Share 99.76 % 71.94 % 32.36 % 59.66 % 76.28 % 1054.95 %
Net Income 10 Yeari Growth Per Share 100 % 404.24 % 35.42 % 59.66 % -133.42 % 470.4 %
Operating Income Growth 69.21 % 6.27 % -56.36 % 9.37 % -84.52 % 0.76 %
Operating Cash Flow Growth (CFG) 72.94 % 23.06 % -26.69 % 1.79 % -13.96 % 14.88 %
Operating 3 Year CFG 99.19 % 14.12 % -29.25 % 48.8 % 10.09 % 62.6 %
Operating 5 Year CFG 99.93 % 37.69 % 118.64 % 166.36 % -48.98 % 275.6 %
Operating 10 Year CFG 100 % 274.61 % 384.17 % 166.36 % -67.94 % 1000.37 %
EPS Growth 44.03 % 12.64 % -54.92 % - 76.42 % 59.01 %
EPS Diluted Growth 44.03 % 12.92 % -54.86 % - 76.42 % 58.33 %
Book Value Per Share -57.53 % 15.25 % 13.54 % 1.35 % -7.25 % 28.15 %
Share Holder 3 Year Equity Growth Per Share -96.94 % 36.7 % 40.38 % -36.6 % -26.74 % 88.86 %
Share Holder 5 Year Equity Growth Per Share -97.25 % 139.55 % 41.33 % -39.41 % -53.44 % 353.33 %
Share Holder 10 Year Equity Growth Per Share -100 % 476.36 % 195.14 % -39.41 % -74.76 % 1167.34 %
Dividend Per Share Growth - 15.15 % 1.95 % -85.58 % - -
Dividend 3 Year Growth Per Share - 87.76 % 1.19 % -83.69 % - -
Dividend 5 Year Growth Per Share - 198.29 % 101.42 % -66.42 % -100 % -
Dividend 10 Year Growth Per Share - 665.58 % 102.58 % -66.42 % -100 % -
Debt Growth -7.53 % -16.5 % 10.53 % -9.43 % -6.53 % 62.95 %
Free Cash Flow Growth 72.94 % 22.25 % -31.4 % 1.67 % -19.19 % 11.99 %
Updated On 30 Jun 2024 31 Dec 2023 31 Mar 2024 31 Dec 2023 31 Dec 2023 31 Dec 2023
Profitability
AYTU ZTS TAK HLN TEVA NBIX
Gross Profit Margin TTM 68.61 % 68.87 % 55.23 % 60.68 % 49.84 % 98 %
Return on Assets TTM -5.4 % 16.93 % 1.99 % 3.26 % -2.38 % 10.92 %
Return on Equity TTM -20.64 % 47.99 % 4.04 % 6.54 % -14.6 % 15.68 %
Return on Capital Employed TTM -8.57 % 26.36 % 4.18 % 7.22 % 1.6 % 18.91 %
Net Income Per EBT TTM 140.26 % 79.65 % 108.74 % 65.38 % 176.38 % 73.98 %
EBT Per Ebit TTM 95.26 % 91.46 % 52.35 % 82.95 % -125.67 % 88.81 %
EBIT Per Revenue TTM -6.2 % 36.45 % 11.21 % 17.82 % 2.67 % 26.19 %
Cash Flow To Debt Ratio TTM -14.3 % 43.6 % 16.58 % - 9.63 % 189.5 %
Receivables Turnover TTM 3.26 6.49 6.3 5.27 4.84 4.66
Payables Turnover TTM 1.75 7.05 4.92 1.23 3.55 0.47
Inventory Turnover TTM 2.02 1.18 1.69 3.03 2.12 0.98
Fixed Asset Turnover TTM 3937.25 % 259.93 % 240.84 % 604.62 % 277.85 % 664.93 %
Asset Turnover TTM 65.16 % 63.75 % 31.2 % 33.71 % 40.16 % 63.45 %
Operating Cash Flow Per Share TTM -0.32 6.5 528.88 - 1.64 4.71
Free Cash Flow Per Share TTM -0.34 5.1 321.24 - 1.21 4.35
Cash Per Share TTM 272.83 % 378.45 % 57241.03 % 5.72 % 292.94 % 1214.64 %
Operating Cash Flow Sales Ratio TTM -3.14 % 32.18 % 18.42 % - 11.07 % 21.24 %
Free Cash Flow Operating Cash Flow Ratio TTM 105.75 % 78.37 % 60.74 % - 73.71 % 92.38 %
Cash Flow Coverage Ratios TTM -14.3 % 43.6 % 16.58 % - 9.63 % 189.5 %
Price To Free Cash Flows Ratio TTM -4.13 33.76 13.12 - 14.86 35.27
Price To Operating Cash Flows Ratio TTM -5.23 26.56 7.96 - 10.94 32.53
Price Cash Flow Ratio TTM -5.23 26.56 7.96 - 10.94 32.53
Income Statement (TTM)
AYTU ZTS TAK HLN TEVA NBIX
Revenue $0.08B $8.54B $4263.76B $11.3B $16.54B $1.89B
Gross Profit $0.05B $5.83B $2832.26B $6.96B $8.06B $1.85B
Gross Profit Ratio 67.39% 68.28% 66.43% 61.59% 48.74% 97.9%
EBITDA $-0B $3.69B $874.6B $2.35B $-0.3B $0.36B
Net Income $-0.02B $2.34B $144.07B $1.05B $-1.64B $0.25B
EPS Diluted -2.86 5.07 91.16 0.11 -1.43 2.47
Balance Sheet (MRQ)
AYTU ZTS TAK HLN TEVA NBIX
Long Term Debt $0.01B $6.75B $5029.93B $8.8B $18.48B $0.26B
Total Liabilities $0.09B $9.3B $7834.79B $17.33B $35.35B $1.02B
Total Equity $0.03B $4.99B $7274.01B $16.73B $8.13B $2.23B
Total Investments $-0B $0.02B $445.7B $0.07B $0.01B $1.63B
Total Debt $0.02B $6.76B $4843.75B $9.46B $20.15B $0.43B
Total Assets $0.12B $14.29B $15108.79B $34.06B $43.48B $3.25B
Cash Flow Statement (TTM)
AYTU ZTS TAK HLN TEVA NBIX
Net Income $-0.02B $2.34B $144.07B $1.11B $-1.96B $0.25B
Inventory $0B $-0.36B $-115.74B $-0.13B $0B $0.01B
Dividends Paid $0B $-0.69B $-287.19B $-0.39B $0B $0B
Operating Cash Flow $-0B $2.35B $716.34B $2.1B $1.25B $0.39B
Capital Expenditure $0B $-0.73B $-480.73B $-0.34B $-0.5B $-0.03B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 3.82
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 1.57
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 12.41
ALVOW Alvotech 2.48
AMPH Amphastar Pharmaceuticals, Inc. 36.37
AMRX Amneal Pharmaceuticals, Inc. 8.58
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 59.56
AQST Aquestive Therapeutics, Inc. 3.08
ASRT Assertio Holdings, Inc. 0.8255
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 7.69
BDSI BioDelivery Sciences International, Inc. 5.59
ETFs With Exposure to AYTU
Ticker ETF Name Weight Percentage Price
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00001 133.21
VXF Vanguard Extended Market Index Fund 0 200.71
PQSV PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Value ETF 0.1 66.2468
DFAT Dimensional U.S. Targeted Value ETF 0.00002482 58
DFAC Dimensional U.S. Core Equity 2 ETF 0.0000058 35.96
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 152.26
DFSU Dimensional US Sustainability Core 1 ETF 0.00015471 39.4565
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 152.27
JKK iShares Morningstar Small-Cap Growth ETF 0 307.42
JKL iShares Morningstar Small-Cap Value ETF 0 172.726
VEMPX Vanguard Extended Market Index InstlPlus 0 375.75
Unlock